Fair Value Determination

Fair value determination under the SEC’s Fair Value Rule requires a registered investment company to determine the fair value of portfolio securities in good faith, using defined methodologies, governance, testing, and recordkeeping. Operationally, you must set up a repeatable valuation program that assesses valuation risk, applies and tests methodologies, oversees pricing services, and documents decisions for board oversight. (17 CFR § 270.2a-5)

Key takeaways:

• “Good faith” fair value is a control system: risk assessment, methodology, testing, oversight, and records. (17 CFR § 270.2a-5)
• Your board can designate a valuation designee (often the adviser), but the board retains oversight. (17 CFR § 270.2a-5)
• Exams typically break down on documentation quality, pricing service oversight, and inconsistent methodology application. (17 CFR § 270.2a-5)

If you own valuation oversight as a CCO or GRC lead, your job is to convert Rule 2a-5 into a program that produces the same outcome every time: a defensible, well-documented fair value conclusion reached in good faith. The rule is not satisfied by having a pricing feed, a valuation memo template, or a valuation committee meeting on the calendar. It is satisfied when your fund can show, end-to-end, how it identifies valuation risk, selects and applies a methodology, validates that methodology remains appropriate, oversees pricing services and other third parties involved in valuation, and preserves records that demonstrate what was done and why. (17 CFR § 270.2a-5)

This page gives you requirement-level implementation guidance you can put into operation quickly: who must comply, what controls to stand up, what artifacts to retain, and where exams typically get stuck. Where tools can help, Daydream can be used to run your valuation control library, evidence collection, third-party oversight workflows for pricing services, and board reporting packages in one place, so the program remains “audit-ready” without heroics.

Regulatory text

Regulatory excerpt (provided): “Registered investment companies must determine the fair value of portfolio securities in good faith.” (17 CFR § 270.2a-5)

Operator interpretation: Rule 2a-5 turns “good faith” into an auditable framework. You must (a) periodically assess material valuation risks, (b) establish and apply fair value methodologies, (c) test whether those methodologies remain appropriate, (d) evaluate pricing service providers, (e) maintain records of fair value determinations, and (f) support board oversight, including a board’s ability to designate a valuation designee (often the adviser). (17 CFR § 270.2a-5)

Plain-English requirement: what “fair value determination” means in practice

Fair value determination is the controlled process you use when market prices are unavailable, unreliable, or need adjustment. In practice, “good faith” means:

• You have defined decision rules for how you value each type of asset.
• You can explain why a price is reasonable, not just state what the price is.
• You detect when a method stops working (market regime shifts, liquidity dries up, stale quotes, unusual spreads).
• You govern the process (roles, escalation, approvals) and give the board what it needs to oversee. (17 CFR § 270.2a-5)

Who it applies to

Entity scope

• Registered investment companies that must fair value portfolio securities. (17 CFR § 270.2a-5)

Operational scope (where this shows up)

• Daily NAV processes, month-end valuation closes, and event-driven valuations (market dislocations, issuer events).
• Instruments with limited observable inputs (thinly traded credit, certain structured products, private positions held by a registered fund).
• Third parties that affect valuation outcomes, especially pricing services and any other external data/model providers you rely on. (17 CFR § 270.2a-5)

Governance note

• The board may designate a valuation designee (typically the adviser) to perform required functions, but the board retains oversight expectations. Your operating model must show what the designee does versus what the board reviews and challenges. (17 CFR § 270.2a-5)

What you actually need to do (step-by-step)

Use the steps below as your build checklist. Treat each step as a control objective with defined inputs, outputs, owners, and evidence.

1) Establish governance and accountability

1. Name the valuation owner(s): valuation designee (if designated), valuation committee, and control owners across Ops, Risk, and Compliance. (17 CFR § 270.2a-5)
2. Define decision rights: who can approve methodology changes, overrides, or exceptions; who escalates to the board; who signs final packages. (17 CFR § 270.2a-5)
3. Board reporting expectations: specify the cadence, minimum content, and triggers for out-of-cycle reporting (for example: material valuation risk changes or significant overrides). (17 CFR § 270.2a-5)

Practical tip: Write one page that maps “valuation events” (stale price, hard-to-price, corporate action, market closure) to the approval path. That page prevents ad hoc behavior.

2) Periodically assess material valuation risks

1. Inventory valuation risk drivers by asset class: liquidity, pricing source quality, model risk, concentration, and operational handoffs. (17 CFR § 270.2a-5)
2. Define what “material” means internally: use qualitative thresholds tied to your fund’s risk profile and board expectations; document the rationale. (17 CFR § 270.2a-5)
3. Set monitoring triggers: conditions that require reassessment (new asset types, new pricing service, market stress, recurring overrides). (17 CFR § 270.2a-5)

Output: a valuation risk assessment that directly links to methodologies and testing plans.

3) Establish and apply fair value methodologies

1. Create a methodology matrix: for each asset type, document primary method, fallback method, key inputs, hierarchy of sources, and when to move from observed price to fair value technique. (17 CFR § 270.2a-5)
2. Document calibration logic: how you validate inputs (quotes, spreads, comparable trades) and adjust when inputs are stale or outliers. (17 CFR § 270.2a-5)
3. Operationalize execution: embed steps into NAV workflows with required fields for exceptions (override reason, approver, supporting evidence). (17 CFR § 270.2a-5)

Control design goal: two different trained analysts should reach the same result, or clearly document why they did not.

4) Test the appropriateness of methodologies

1. Define testing types: back-testing (compare to subsequent trades), variance analysis (price movements vs market factors), override trend analysis, and challenge reviews for hard-to-price names. (17 CFR § 270.2a-5)
2. Set ownership and independence: testing should be performed or reviewed by a function that can challenge portfolio management incentives (often Risk/Valuation Control). (17 CFR § 270.2a-5)
3. Document outcomes and changes: when testing indicates drift, record the conclusion and any methodology update, including board communication where required. (17 CFR § 270.2a-5)

Common hangup: teams “test” but do not define pass/fail criteria or escalation triggers. Your testing plan needs decision rules.

5) Evaluate and oversee pricing service providers (third parties)

1. Due diligence the provider: understand data sources, methodologies, coverage limitations, and controls that affect price quality. (17 CFR § 270.2a-5)
2. Define ongoing oversight: periodic performance reviews, exception reporting, and issue management (stale prices, missing prices, unexplained changes). (17 CFR § 270.2a-5)
3. Contract and SLA alignment: ensure contractual terms support your oversight (transparency, change notifications, audit support) and align to your valuation risk. (17 CFR § 270.2a-5)

How Daydream fits: use Daydream to run third-party due diligence workflows for pricing services, track open issues, and attach evidence to each review cycle so board reporting is assembled from system-of-record artifacts rather than email threads.

6) Maintain records that prove “good faith”

1. Record each fair value determination’s support: inputs, source hierarchy followed, overrides and approvals, and reasonableness checks. (17 CFR § 270.2a-5)
2. Retain governance records: committee minutes, methodology approvals, testing reports, and board materials. (17 CFR § 270.2a-5)
3. Keep audit trails: who changed what and when, especially for price overrides and methodology updates. (17 CFR § 270.2a-5)

Required evidence and artifacts to retain (exam-ready list)

Maintain these as a standard “valuation evidence pack”:

• Valuation policies and procedures aligned to Rule 2a-5 requirements. (17 CFR § 270.2a-5)
• Valuation risk assessments and updates tied to portfolio changes and market conditions. (17 CFR § 270.2a-5)
• Methodology matrix by asset type with triggers for fair value and fallback methods. (17 CFR § 270.2a-5)
• Methodology testing plan and results, including exceptions, conclusions, and remediation items. (17 CFR § 270.2a-5)
• Pricing service provider due diligence file and ongoing oversight reports. (17 CFR § 270.2a-5)
• Override logs with approver, rationale, and supporting documentation. (17 CFR § 270.2a-5)
• Board and committee materials: reports, minutes, escalations, and approvals. (17 CFR § 270.2a-5)

Common exam/audit questions and hangups

Expect reviewers to probe these areas:

• “Show me how you determined fair value in good faith for these sample positions, including inputs, assumptions, and approvals.” (17 CFR § 270.2a-5)
• “What are your material valuation risks, and how did they change over time?” (17 CFR § 270.2a-5)
• “How do you test that your methodology remains appropriate? What happens when it fails?” (17 CFR § 270.2a-5)
• “How do you oversee your pricing service? What evidence shows challenge, not acceptance?” (17 CFR § 270.2a-5)
• “If the adviser is the valuation designee, what does the board receive and how does it oversee?” (17 CFR § 270.2a-5)

Hangup pattern: the policy says one thing, the workflow does another. Examiners focus on operational reality.

Frequent implementation mistakes (and how to avoid them)

Mistake	Why it fails	Fix
Treating fair value as a “pricing issue” owned only by Fund Accounting	Rule 2a-5 is governance + risk + testing + oversight + records	Assign cross-functional ownership; document decision rights. (17 CFR § 270.2a-5)
No documented triggers for moving to fair value	Creates ad hoc decisions and inconsistent results	Define instrument-specific triggers and embed in procedures. (17 CFR § 270.2a-5)
Weak pricing service oversight	You cannot show good faith if you cannot explain inputs and limitations	Perform documented due diligence and periodic performance review; track issues to closure. (17 CFR § 270.2a-5)
Testing exists but has no consequence	“Testing theater” does not show methodology appropriateness	Write pass/fail criteria and required actions; show remediation and board visibility. (17 CFR § 270.2a-5)
Over-reliance on email for approvals	Audit trail becomes incomplete	Centralize approvals, override logs, and attachments in a controlled system (Daydream or equivalent). (17 CFR § 270.2a-5)

Enforcement context and risk implications

No public enforcement case sources were provided for this page, so do not treat this as enforcement-specific guidance. Your practical risk is exam deficiency and remediation risk when you cannot evidence “good faith” through repeatable process, oversight of pricing services, testing results, and board reporting. (17 CFR § 270.2a-5)

Practical execution plan (30/60/90-day)

Use phased delivery tied to artifacts, not calendar promises.

First 30 days (stabilize and map)

• Confirm governance model: board oversight expectations, valuation designee scope, committee charter, escalation paths. (17 CFR § 270.2a-5)
• Build the asset-by-asset methodology inventory and identify gaps where triggers or fallback methods are missing. (17 CFR § 270.2a-5)
• Stand up a centralized evidence repository (Daydream can serve as the system of record) and define required evidence for overrides and exceptions. (17 CFR § 270.2a-5)

Next 60 days (standardize and test)

• Complete a documented valuation risk assessment mapped to asset classes and pricing sources. (17 CFR § 270.2a-5)
• Implement methodology testing routines and reporting formats; start collecting results and documenting actions. (17 CFR § 270.2a-5)
• Complete pricing service provider evaluations and define ongoing oversight deliverables (performance review pack, issue log). (17 CFR § 270.2a-5)

Next 90 days (operate and prove)

• Run at least one full cycle of board reporting under the new framework: risks, methodology changes, testing outcomes, pricing service oversight, exceptions. (17 CFR § 270.2a-5)
• Perform a mock exam sample: pick a set of hard-to-price positions and produce complete evidence packs on demand. (17 CFR § 270.2a-5)
• Close gaps: rewrite procedures where operations diverged, retrain owners, and tighten approval and recordkeeping controls. (17 CFR § 270.2a-5)

Frequently Asked Questions

Does Rule 2a-5 require the board to do the valuations?

The rule allows the board to designate a valuation designee (often the adviser) to perform the required functions, subject to board oversight. You still need a board reporting and challenge process that is evidenced in materials and minutes. (17 CFR § 270.2a-5)

If we use a pricing service, are we “done” for fair value?

No. The rule expects you to evaluate pricing service providers and maintain records supporting fair value determinations. You must also assess valuation risks, apply methodologies, and test appropriateness over time. (17 CFR § 270.2a-5)

What is the minimum documentation for a price override?

Keep the original price, the override price, the reason for the override tied to your methodology triggers, supporting inputs, and the approval/audit trail. Retain it in a searchable log that can be sampled in an exam. (17 CFR § 270.2a-5)

How do we show “good faith” without writing a memo for every position every day?

Build a rules-based methodology matrix and require enhanced documentation only for exceptions: fair-valued positions, overrides, stale/missing prices, or methodology changes. Your baseline process still needs consistent logs and controls. (17 CFR § 270.2a-5)

Who should own methodology testing: Compliance, Risk, or Fund Accounting?

Rule 2a-5 requires testing but does not prescribe the department. Most firms assign testing to a valuation control or risk function with authority to challenge, while accounting executes daily workflows and compliance oversees governance and evidence quality. (17 CFR § 270.2a-5)

What should we ask a pricing service during evaluation?

Focus on what you need to defend prices: data sources, methodology coverage by instrument, how they handle stale markets, change management notifications, and what evidence they can provide to support your oversight file. Document the answers and how you monitor performance. (17 CFR § 270.2a-5)